RxDoctor Payments DataLook up a doctor →

Howard Schecht, MD

Neurology · Toledo, OHNPI 1710984711

Payments from drug & device makers

$563,582in general payments, 2019–2025

Across 2,000 payments — averaging $281.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$292K
  • Amgen$76K
  • AbbVie$51K
  • Teva Pharmaceuticals USA, Inc.$44K
  • EMD Serono, Inc.$30K
  • Roche Products Limited$27K
  • plus $44K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis155$292,045
Amgen(2 entities)99$75,617
AbbVie(2 entities)227$50,860
Teva Pharmaceuticals USA, Inc.183$43,726
EMD Serono, Inc.182$29,983
Roche Products Limited33$27,199
Biogen157$20,791
Sanofi30$2,598
Amneal Pharmaceuticals LLC25$2,572
MDD US Operations, LLC105$2,077
E.r. Squibb & Sons, L.L.C.5$1,778
AstraZeneca(2 entities)50$1,075
Acadia Pharmaceuticals Inc79$1,054
UCB, Inc.60$1,013
Genentech USA, Inc.50$894
SK Life Science, Inc.42$795
Bristol Myers Squibb24$787
Lilly USA, LLC52$745
CSL Behring35$629
Lundbeck LLC40$617
Pfizer33$531
Supernus Pharmaceuticals, Inc.36$495
Johnson & Johnson26$446
Mallinckrodt Hospital Products Inc.2$364
Eisai Inc.20$363
TG Therapeutics, Inc.15$340
Kyowa Kirin, Inc.14$333
Takeda Pharmaceuticals U.S.A., Inc.14$301
Acorda Therapeutics, Inc16$295
Adamas Pharmaceuticals, Inc.24$264
Vanda Pharmaceuticals Inc.10$242
Biohaven Pharmaceutical Holding Company Ltd.20$231
Avanir Pharmaceuticals, Inc.11$192
Neurelis, Inc.9$175
Biohaven Pharmaceuticals, Inc.11$166
Argenx US, Inc.7$152
Alnylam Pharmaceuticals Inc.6$121
Upsher-smith Laboratories LLC5$121
Otsuka America Pharmaceutical, Inc.6$116
Axsome Therapeutics, Inc.6$100
Jazz Pharmaceuticals Inc.4$92
Assertio Therapeutics, Inc.5$77
Banner Life Sciences, LLC4$74
Impel Pharmaceuticals Inc.4$69
Amylyx Pharmaceuticals, Inc.3$66
Almatica Pharma LLC4$63
Catalyst Pharmaceuticals, Inc.4$61
Livanova USA, Inc.4$60
Nobelpharma America, LLC1$58
Tanabe Pharma America, Inc.4$53
Merz Pharmaceuticals, LLC3$51
Avadel CNS Pharmaceuticals, LLC1$50
Genentech, Inc.1$48
Neurocrine Biosciences, Inc.3$47
Bausch Health US, LLC2$45
Grifols USA, LLC3$41
Greenwich Biosciences, Inc.2$39
Aprecia Pharmaceuticals, LLC2$39
Arbor Pharmaceuticals, Inc.3$38
Mylan Specialty L.p.2$38

How this compares

$563,582 in reported general payments places this provider in the 90th percentile of 702 neurology providers in Ohio.

See all neurology providers in Ohio →

Medicare billing

Part B allowed, 2024
$137,956
Medicare patients
678
Services billed
1,844

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Toledo

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →